Home / NCIMI partners one step closer to large scale AI adopti…
NCIMI partners one step closer to large scale AI adoption
April 29, 2021
Caristo Diagnostics CaRi-Heart®
Working closely with the British Heart Foundation, Caristo has received CE-marking for its innovation: CaRi-Heart®️ cardiovascular risk prediction service.
It means patients in the UK and Europe can now benefit from personalised, accurate predictions of their risk of heart attack based on coronary inflammation.
The first-of-its-kind technology, CaRi-Heart® has the power to detect ‘invisible’ risk in people with possible heart disease by using routine heart scans already performed in clinical practice.
Optellum Virtual Nodule Clinic
Meanwhile, Optellum has received national press attention for its lung cancer diagnostic technology, Virtual Nodule Clinic.
Coverage on with inews and BBC South Today sets out what this could mean for the NHS and patients in the UK.
Meet the team: Dr Mackenzie Graham, NCIMI’s Senior Research Fellow: Imaging & Data Ethics
June 15, 2021
Mackenzie is a Senior Researcher with the Wellcome Centre for Ethics and Humanities, and the Junior Research Fellow in the Humanities at…
PathLAKE webinar: Research Ethics Committee Review of AI projects
June 2, 2021
NCIMI backed study confirms longer-term lung damage after COVID-19
May 25, 2021
Brainomix’s e-Stroke software goes live across Sussex
May 4, 2021